ClinicalTrials.gg
CompletedNCT06280365Updated Nov 18, 2026

MWM Technique in Patients With Knee OA

An interventional study of Mulligan Mobilization with Movement Technique in Mobilization, sponsored by Okan University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 25 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Okan University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 2 years 2 months after the study started (first participant enrolled Nov 2021, registered Feb 2024).
Updated Nov 18, 2026First site in Turkey (Türkiye)No longer in Turkey+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
25 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 268 studies in Osteoarthritis, Knee with a site in Turkey — 52 open to participants now, 63 under way, 3 of them phase 3. Osteoarthritis, Knee · Turkey.

Enrollment
173rd of 198
30 · median 60
Started
2021
with 16 others
No phase
189 of 268
30 open now
Registered
134th of 268
by date

Among the 268 studies in Osteoarthritis, Knee with a site in Turkey, this one is the 173rd largest by enrollment of the 198 interventional ones that give a count, is one of 17 that started in 2021, is one of 189 with no phase, and was the 134th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

52 of the 268 studies in Osteoarthritis, Knee with a site in Turkey are open now. Recruiting first, the newest first:

47 more — sign in →

All 52 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 25 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 268 studies in Osteoarthritis, Knee with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to investigate the effect of the MWM technique on pain, normal joint movement, proprioception and quality of life in patients with knee osteoarthritis (OA).

Read the detailed description

The aim of this study is to investigate the effect of the MWM technique on pain, normal joint movement, muscle strength, proprioception, mobility, balance, functionality and quality of life in patients with knee OA.

03

Conditions studied

  • Mobilization

Keywords

  • Knee Osteoarthritis
  • Mobilization
  • Proprioception
  • Pain
04

Who can participate

Ages eligible
25 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • being diagnosed with knee osteoarthritis,
  • being diagnosed with knee OA at the earliest 6 months ago

Exclusion criteria

Exclusion Criteria:

  • Participants who were pregnant,
  • had knee surgery, had an infection,
  • had a pacemaker, had an infraction,
  • had cancer, or were receiving treatment were excluded from the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    MWM group

    Participants in group 2 will receive MWM technique treatment 3 times a week for 4 weeks. The patient should lie face down with a pillow over the knee and the physiotherapist should stand on the contralateral side for the application. The physiotherapist passes the belt around the waist to the patient's tibia edge. The knee is stabilized with one hand while the leg is supported with the other hand. The knee is moved medially without applying too much force through the belt and the patient is asked to stretch. If there is no pain, the movement is indicated. If pain occurs during the movement, the same procedure is performed for the lateral side by changing the position. It is important that the arch remains horizontal and does not cause rotation of the hip. The movement will be repeated 3 times at the point where there is no pain.

    Other: Mulligan Mobilization with Movement Technique

  • No intervention
    Control Group

    Participants in group 1 will receive conservative treatment 3 times a week for 4 weeks. Conservative treatment includes hot packs and traditional transcutaneous electrical nerve stimulation (TENS), an electrotherapy. All participants in the study will receive 20 minutes of hot pack application to the knee area each session by a physiotherapist. All participants in the study will receive TENS for 20 minutes each session from the physiotherapist, who will place personalized electrodes around the knee joint and adjust the current to the level the person can tolerate.

Interventions

  • OtherMulligan Mobilization with Movement Technique

    Mobilization Technique

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale (VAS)

    VAS, which digitizes parameter values that cannot be measured numerically, was used to evaluate the pain intensity of the participants. The two extreme values of the parameter to be measured are written on the scale as 0 and 10. The person is asked to mark the value that best suits him/her on the scale. For pain, no pain and very severe pain; It is specified as 0 and 10. The person chooses a value according to his/her pain

    Time frame: 4 week change in pain intensity

  2. Short form-36 (SF-36)

    SF-36, developed in 1992, consists of 36 items providing measurement to the following 8 dimensions: physical functioning (10 items), social functioning (2 items), role limitations due to physical problems (4 items), role limitations due to emotional problems (3 items), mental health (5 items), energy/vitality (4 items), pain (2 items), and general health perception (5 items). An increase in the score indicates a higher rate of improvement in health status.

    Time frame: 4-week change in quality of life

  3. Western Ontario and Mcmaster Universities Osteoarthritis Index (WOMAC)

    This survey is conducted to evaluate how much the routine activities in the participants' lives are affected by the knee problem. The survey included the following parameters: pain, physical function, and stiffness. A Likert system ranging from 1 to 5 is used. As the value increases, the intensity of the parameters increases

    Time frame: 4-week

  4. Evaluation of proprioception

    To assess the participants' sense of proprioception, the method of actively reproducing the passive position without supporting the limb was used. In this assessment, where the angle is measured with a goniometer, the person closes their eyes. The limb is passively moved to the target angle and the person is asked to concentrate on the position. After 10 seconds, the starting point of the movement is returned. The person tries to find the target angle by actively moving the same limb. If the angle achieved at the end of the movement is different from the target angle, the difference is recorded as the deviation angle (used to 15° and 45° knee flexion).

    Time frame: 4-week change in proprioception

  5. The range of motion

    A goniometer (Baseline plastic goniometer), which provides numerical and objective results, was used to measure the range of motion of the participants. Knee flexion for normal range of motion in the knee region and knee extension angles were evaluated.

    Time frame: 4-week

07

Study locations

1 site
  • Emine Atıcı
    Tuzla, Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2021 to primary completion in Mar 2022, 4 months.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's 4 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: start May 2024 → Nov 2021, primary completion Jul 2024 → Mar 2022 and completion Jul 2024 → Mar 2022.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2024
First posted
Feb 28, 2024
StartActual
Nov 6, 2021was May 2024
Primary completionActual
Mar 30, 2022was Jul 2024
CompletionActual
Mar 30, 2022was Jul 2024
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed — first site in Turkey (Türkiye); no longer in Turkey
Show site
  • Emine Atıcı · Tuzla, Turkey (Türkiye)
Show 1 removed
  • Emine Atıcı · Tuzla, Turkey
Nov 18, 2026
Start date
May 6, 2024→Nov 6, 2021
Nov 18, 2026
Primary completion
Jul 30, 2024→Mar 30, 2022
Nov 18, 2026
Study completion
Jul 30, 2024→Mar 30, 2022
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    1 site added, 1 site removed — first site in Turkey (Türkiye); no longer in Turkey
    Show site
    • Emine Atıcı · Tuzla, Turkey (Türkiye)
    Show 1 removed
    • Emine Atıcı · Tuzla, Turkey
    Start date May 6, 2024→Nov 6, 2021
    Primary completion Jul 30, 2024→Mar 30, 2022
    Study completion Jul 30, 2024→Mar 30, 2022
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06280365
Lead sponsor
Okan University
Responsible party
Emine Atıcı (Principal Investigator, Okan University) — Principal investigator
First posted
Feb 28, 2024
Start date
Nov 6, 2021
Primary completion
Mar 30, 2022
Completion
Mar 30, 2022
Last update
Nov 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion